The New Zealand cervical cancer study: could it happen again?
Open Access
- 20 August 1988
- Vol. 297 (6647) , 533-539
- https://doi.org/10.1136/bmj.297.6647.533
Abstract
The author is one of the medical advisers to the judge who led a government inquiry into allegations that an experimental research program at the National Women's Hospital in Auckland, New Zealand, to study the natural course of cervical carcinoma in situ had withheld conventional treatment from some patients. She argues that the research proposal should not have been approved at the outset, that consent should have been sought from the patients, that the study was not monitored adequately, and that the concerns of other doctors were not acted on. The reasons for this failure to protect the safety of patients go beyond the individual researcher and must be sought in the attitudes of doctors to science, to accountability, and perhaps to women.Keywords
This publication has 15 references indexed in Scilit:
- CARCINOMA INSITU OF THE VULVA - A REVIEW OF 31 TREATED AND 5 UNTREATED CASES1986
- THE INVASIVE POTENTIAL OF CARCINOMA INSITU OF THE CERVIX1984
- The critical attitude in medicine: the need for a new ethics.BMJ, 1983
- Clinical trials: Retrospect and prospectStatistics in Medicine, 1982
- The progression of pre-invasive lesions of the cervix to invasion.1974
- Cervical Carcinoma in SituAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1970
- Vaginal carcinoma in situ following hysterectomy.1969
- Medical Ethics and Controlled TrialsBMJ, 1963
- Significance of in situ Carcinoma of the Uterine CervixBMJ, 1962
- Spontaneous course of cervical precancerous conditionsAmerican Journal of Obstetrics and Gynecology, 1956